Explore the science behind cyclin-dependent kinases (CDKs), their role in cancer progression, and the breakthrough inhibitors revolutionizing cancer treatment.
Explore the groundbreaking research on USP7 inhibitors as a promising cancer therapy targeting protein stability and immune response activation.